A randomized controlled Trial of telerehabilitation intervention for acute ischemic stroke patients Post-Discharge

IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY
Shihao Sun , Yu Li , Gang Zhang , Yong Zhang , Jun Dong
{"title":"A randomized controlled Trial of telerehabilitation intervention for acute ischemic stroke patients Post-Discharge","authors":"Shihao Sun ,&nbsp;Yu Li ,&nbsp;Gang Zhang ,&nbsp;Yong Zhang ,&nbsp;Jun Dong","doi":"10.1016/j.jocn.2025.111245","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The acute ischemic stroke (AIS) represents a significant contributor to global disability and mortality rates. Effective rehabilitation interventions play a critical role in enhancing patients’ functional recovery and overall quality of life. With the advancement of telemedicine technology, post-discharge telerehabilitation interventions are becoming increasingly feasible, yet their efficacy requires validation through randomized controlled trials (RCT). This study aimed to evaluate the efficacy of a 12-week telerehabilitation program compared to standard post-discharge care in AIS patients.</div></div><div><h3>Methods</h3><div>This study employed a randomized controlled design, enrolling 200 patients who had been discharged after an AIS. Participants were randomly assigned to either the intervention group or the control group in a 1:1 ratio. The intervention group received a 12-week telerehabilitation program, which included a personalized rehabilitation training plan, regular video consultations, and health education. The control group received standard post-discharge care, which consisted of a rehabilitation manual and biweekly outpatient follow-ups for up to 12 weeks. The primary outcome measure was the Barthel Index, assessing patients’ ability to perform activities of daily living. Secondary outcome measures included the modified Rankin Scale (mRS, assessing the degree of disability), Hamilton Depression Rating Scale (HAMD, assessing the patients’ mental health status), and World Health Organization Quality of Life-BREF (WHOQOL-BREF, assessing the patients’ quality of life).</div></div><div><h3>Results</h3><div>The mean score of the Barthel Index in the intervention group improved significantly from a baseline of 65.4 ± 12.3 to 88.7 ± 9.6, while the control group improved from 65.6 ± 12.1 to 74.9 ± 13.2 (P &lt; 0.001). The mRS showed that 75 patients (75 %) in the intervention group achieved scores of 0–2 (no symptoms or mild disability), compared to 62 patients (62 %) in the control group, with significant improvement in the intervention group (P = 0.003). The HAMD scores indicated a significant reduction from a baseline of 17.5 ± 4.2 to 9.6 ± 3.1 in the intervention group, compared to a reduction from 17.3 ± 4.0 to 13.2 ± 4.5 in the control group (P &lt; 0.001). The WHOQOL-BREF scores in the intervention group were significantly higher than those in the control group across all four domains: physical health, psychological health, social relationships, and environment (P &lt; 0.05).</div></div><div><h3>Conclusion</h3><div>The findings of this study support telerehabilitation interventions as an effective rehabilitation method, significantly improving the rehabilitation outcomes and quality of life of patients discharged after mild AIS, and potentially reducing the risk of recurrence.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"136 ","pages":"Article 111245"},"PeriodicalIF":1.9000,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0967586825002176","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

The acute ischemic stroke (AIS) represents a significant contributor to global disability and mortality rates. Effective rehabilitation interventions play a critical role in enhancing patients’ functional recovery and overall quality of life. With the advancement of telemedicine technology, post-discharge telerehabilitation interventions are becoming increasingly feasible, yet their efficacy requires validation through randomized controlled trials (RCT). This study aimed to evaluate the efficacy of a 12-week telerehabilitation program compared to standard post-discharge care in AIS patients.

Methods

This study employed a randomized controlled design, enrolling 200 patients who had been discharged after an AIS. Participants were randomly assigned to either the intervention group or the control group in a 1:1 ratio. The intervention group received a 12-week telerehabilitation program, which included a personalized rehabilitation training plan, regular video consultations, and health education. The control group received standard post-discharge care, which consisted of a rehabilitation manual and biweekly outpatient follow-ups for up to 12 weeks. The primary outcome measure was the Barthel Index, assessing patients’ ability to perform activities of daily living. Secondary outcome measures included the modified Rankin Scale (mRS, assessing the degree of disability), Hamilton Depression Rating Scale (HAMD, assessing the patients’ mental health status), and World Health Organization Quality of Life-BREF (WHOQOL-BREF, assessing the patients’ quality of life).

Results

The mean score of the Barthel Index in the intervention group improved significantly from a baseline of 65.4 ± 12.3 to 88.7 ± 9.6, while the control group improved from 65.6 ± 12.1 to 74.9 ± 13.2 (P < 0.001). The mRS showed that 75 patients (75 %) in the intervention group achieved scores of 0–2 (no symptoms or mild disability), compared to 62 patients (62 %) in the control group, with significant improvement in the intervention group (P = 0.003). The HAMD scores indicated a significant reduction from a baseline of 17.5 ± 4.2 to 9.6 ± 3.1 in the intervention group, compared to a reduction from 17.3 ± 4.0 to 13.2 ± 4.5 in the control group (P < 0.001). The WHOQOL-BREF scores in the intervention group were significantly higher than those in the control group across all four domains: physical health, psychological health, social relationships, and environment (P < 0.05).

Conclusion

The findings of this study support telerehabilitation interventions as an effective rehabilitation method, significantly improving the rehabilitation outcomes and quality of life of patients discharged after mild AIS, and potentially reducing the risk of recurrence.
急性缺血性脑卒中患者出院后远程康复干预的随机对照试验
背景:急性缺血性中风(AIS)是全球致残率和死亡率的一个重要因素。有效的康复干预对提高患者的功能恢复和整体生活质量起着至关重要的作用。随着远程医疗技术的进步,出院后远程康复干预变得越来越可行,但其有效性需要通过随机对照试验(RCT)来验证。本研究旨在评估与标准出院后护理相比,12周远程康复计划对AIS患者的疗效。方法本研究采用随机对照设计,纳入200例AIS后出院的患者。参与者按1:1的比例被随机分配到干预组或对照组。干预组接受为期12周的远程康复计划,包括个性化康复训练计划、定期视频咨询和健康教育。对照组接受标准的出院后护理,包括康复手册和两周一次的门诊随访,随访时间长达12周。主要结局指标是Barthel指数,评估患者进行日常生活活动的能力。次要结局指标包括改良Rankin量表(mRS,评估残疾程度)、汉密尔顿抑郁评定量表(HAMD,评估患者心理健康状况)和世界卫生组织生活质量量表(WHOQOL-BREF,评估患者生活质量)。结果干预组Barthel指数平均评分由基线65.4±12.3提高到88.7±9.6,对照组由65.6±12.1提高到74.9±13.2 (P <;0.001)。mRS显示干预组75例(75%)患者达到0-2分(无症状或轻度残疾),对照组62例(62%),干预组有显著改善(P = 0.003)。干预组HAMD评分从基线17.5±4.2降至9.6±3.1,对照组从17.3±4.0降至13.2±4.5 (P <;0.001)。干预组在身体健康、心理健康、社会关系和环境四个领域的WHOQOL-BREF得分均显著高于对照组(P <;0.05)。结论本研究结果支持远程康复干预作为一种有效的康复方法,可显著改善轻度AIS患者出院后的康复效果和生活质量,并有可能降低复发风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical Neuroscience
Journal of Clinical Neuroscience 医学-临床神经学
CiteScore
4.50
自引率
0.00%
发文量
402
审稿时长
40 days
期刊介绍: This International journal, Journal of Clinical Neuroscience, publishes articles on clinical neurosurgery and neurology and the related neurosciences such as neuro-pathology, neuro-radiology, neuro-ophthalmology and neuro-physiology. The journal has a broad International perspective, and emphasises the advances occurring in Asia, the Pacific Rim region, Europe and North America. The Journal acts as a focus for publication of major clinical and laboratory research, as well as publishing solicited manuscripts on specific subjects from experts, case reports and other information of interest to clinicians working in the clinical neurosciences.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信